Impact of Tocilizumab Monotherapy on Clinical and Patient-Reported Quality-of-Life Outcomes in Patients with Rheumatoid Arthritis

INTRODUCTION: Tocilizumab (TCZ) monotherapy has been proven as an effective treatment for rheumatoid arthritis (RA) in clinical trials. However, there are limited data available regarding the effectiveness of TCZ monotherapy in real-world clinical settings in the United States. The objective of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrold, Leslie R., John, Ani, Reed, George W., Haselkorn, Tmirah, Karki, Chitra, Li, YouFu, Best, Jennie, Zlotnick, Steve, Kremer, Joel M., Greenberg, Jeffrey D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696293/
https://www.ncbi.nlm.nih.gov/pubmed/28936808
http://dx.doi.org/10.1007/s40744-017-0081-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696293/
https://www.ncbi.nlm.nih.gov/pubmed/28936808
http://dx.doi.org/10.1007/s40744-017-0081-3

Ejemplares similares